Rational Fluid Therapy in Germany

Ludwig-Maximilians - University of Munich4,000 enrolled

Overview

The purpose of this observational study is the prospective documentation and evaluation of the status quo of volume therapy in German intensive care units.

The purpose of RaFTinG is the prospective documentation and evaluation of the demographic, diagnostic and therapeutic characteristics of unselected patients and their treatment in intensive care units (ICU) in Germany. Documentation will not only include their stay in the ICU but a follow up query 90 days after discharge from the ICU.

Study Type

OBSERVATIONAL

Enrollment

4,000

Conditions

Patients in ICU

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * ICU patients with an indication for fluid/volume therapy Exclusion Criteria: * Patients hospitalized by order of a court of law or a government agency

Locations (2)

Klinik für Anaesthesiologie, Klinikum der Universität München

Munich, Bavaria, Germany

Universitätsklinikum Münster

Münster, North Rhine-Westphalia, Germany

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.